| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 13
| Issue : 1 | Page : 43-47 |
|
|
Knowledge, attitudes, and perception of 398 cancer patients toward participation in clinical trials: A single-center study from New Delhi, India
Vishal Kumar Biswkarma1, Nitesh Rohatgi2, Rajesh Saxena3, SK Gupta1
1 Department of Clinical Research, Delhi Institute of Pharmaceutical Science and Research, New Delhi, India
2 Department of Medical Oncology, Max Super Speciality Hospital, New Delhi, India
3 Office of Research, Max Healthcare, New Delhi, India
Correspondence Address:
Dr. S K Gupta
Department of Clinical Research, Delhi Institute of Pharmaceutical Science and Research, New Delhi - 110 017
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/picr.PICR_177_19
|
|
|
Background and Objective: Clinical trials are considered to be the gold standard research methodology for evaluating the efficacy and safety of healthcare interventions.
Materials and Methods: A cross-sectional study was conducted using standardized self-administered questionnaires prepared by the research team and statistician. The questionnaires were offered to cancer patients presented at a tertiary care center.
Results: We surveyed 398 cancer patients, 193 (48.5%) males and 205 (51.5%) females with a mean (±standard deviation) 55.39 (±13.59) of age in years. Out of total, only 59 (14.82%) had the prior knowledge of the clinical trial. Forty-three (10.80%) participants were willing to participate in clinical trials.
Conclusion: Cancer patients had preconceived notions and myths that linger in our society that clinical trial participation will harm them. The researchers/oncologists need to explore the rationale, objectives, and benefits of taking part in clinical trials and make it easy to understand by cancer patients. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
